This collection
is approved with changes made in the revised survey and follow-up
letters sent from FDA to OMB and included with the OMB file. In
addition, if the response rate for a survey is less than 70%
(rounded to the nearest percent) two weeks after the third round of
follow-up letters is sent to those who have not responded, a round
of follow-up phone calls will be conducted by FDA. These calls will
begin two weeks after the third follow-up letter, and all those who
have not responded will be called once. In the next request for
clearance of this collection, FDA will report on the costs and
benefits of the follow-up phone calls, and this method will be
reevaluated.
Inventory as of this Action
Requested
Previously Approved
07/31/2003
07/31/2003
06/30/2000
924
0
924
157
0
157
0
0
0
This proposed survey would collect
information from a sample of FDa Safety Alert/Public Health
Advisory recipients. FDA will use the information to evaluate the
usefulness of these publications and to improve its methods of
communicating medical device risks to health care
professionals.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.